MARKET

TCMD

TCMD

Tactile Systems
NASDAQ
12.86
+0.08
+0.63%
After Hours: 12.86 0 0.00% 16:02 05/24 EDT
OPEN
12.87
PREV CLOSE
12.78
HIGH
12.96
LOW
12.62
VOLUME
248.70K
TURNOVER
0
52 WEEK HIGH
26.11
52 WEEK LOW
9.70
MARKET CAP
305.58M
P/E (TTM)
10.87
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TCMD last week (0520-0524)?
Weekly Report · 11h ago
Tactile Medical to Present at the William Blair 44th Annual Growth Stock Conference
Tactile Systems Technology, Inc. Will participate in the William Blair 44th Annual Growth Stock Conference in Chicago, IL on June 4th and 6th. The company provides therapies for people with chronic disorders. Management will also participate in a fireside chat on Tuesday, June 4.
Barchart · 6d ago
Weekly Report: what happened at TCMD last week (0513-0517)?
Weekly Report · 05/20 10:36
Weekly Report: what happened at TCMD last week (0506-0510)?
Weekly Report · 05/13 10:43
Tactile Systems: Report of proposed sale of securities
Press release · 05/08 20:12
Oppenheimer Remains a Buy on Tactile Systems Technology (TCMD)
TipRanks · 05/07 12:18
Tactile Systems Technology (TCMD) Gets a Buy from Piper Sandler
TipRanks · 05/07 12:07
TCMD Stock Earnings: Tactile Systems Tech Beats EPS, Beats Revenue for Q1 2024
Tactile Systems Tech reported earnings per share of -5 cents for the first quarter of 2024. The company reported revenue of $61.09 million. This was 3.24% better than the analyst estimate for the same period. Tactile systems tech also reported results for the fourth quarter of 2015.
Investorplace · 05/07 00:57
More
About TCMD
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

Webull offers Tactile Systems Technology Inc stock information, including NASDAQ: TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.